Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F (2017) Diagnostic challenges in meningioma. Neuro Oncol 19:1588–1598. https://doi.org/10.1093/neuonc/nox101
Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro Oncol 19:1298–1307. https://doi.org/10.1093/neuonc/nox071
Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347–354. https://doi.org/10.1227/NEU.0000000000000461. (discussion 354 – 345; quiz 355)
Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR, Kim AH (2014) Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 75:356–363. https://doi.org/10.1227/NEU.0000000000000462. (discussion 363)
Banan R, Abbetmeier-Basse M, Hong B, Dumitru CA, Sahm F, Nakamura M, Krauss JK, Hartmann C (2021) The prognostic significance of clinicopathological features in meningiomas: microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol Appl Neurobiol 47:724–735. https://doi.org/10.1111/nan.12700
Baumgarten P, Gessler F, Schittenhelm J, Skardelly M, Tews DS, Senft C, Dunst M, Imoehl L, Plate KH, Wagner M, Steinbach JP, Seifert V, Mittelbronn M, Harter PN (2016) Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132:479–481. https://doi.org/10.1007/s00401-016-1598-1
Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Renovanz M, Skardelly M, Bornemann A, Honegger J, Tabatabai G, Tatagiba M, Schittenhelm J (2020) CNS invasion in meningioma-how the intraoperative assessment can improve the prognostic evaluation of tumor recurrence. Cancers. https://doi.org/10.3390/cancers12123620
Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C, Schichor C (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469–477. https://doi.org/10.1007/s11060-019-03312-x
Backer-Grondahl T, Moen BH, Arnli MB, Torseth K, Torp SH (2014) Immunohistochemical characterization of brain-invasive meningiomas. Int J Clin Exp Pathol 7:7206–7219
Spille DC, Hess K, Sauerland C, Sanai N, Stummer W, Paulus W, Brokinkel B (2016) Brain Invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 93:346–354. https://doi.org/10.1016/j.wneu.2016.06.055
Behling F, Hempel JM, Schittenhelm J (2021) Brain invasion in meningioma—a prognostic potential worth exploring. Cancers. https://doi.org/10.3390/cancers13133259
Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465. https://doi.org/10.1097/00000478-199712000-00008
Friconnet G, Espindola Ala VH, Janot K, Brinjikji W, Bogey C, Lemnos L, Salle H, Saleme S, Mounayer C, Rouchaud A (2019) MRI predictive score of pial vascularization of supratentorial intracranial meningioma. Eur Radiol 29:3516–3522. https://doi.org/10.1007/s00330-019-06197-6
Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougere C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF, International Consortium on M (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol 21:i44–i61. https://doi.org/10.1093/neuonc/noy143
Ong T, Bharatha A, Alsufayan R, Das S, Lin AW (2021) MRI predictors for brain invasion in meningiomas. Neuroradiol J 34:3–7. https://doi.org/10.1177/1971400920953417
Joo L, Park JE, Park SY, Nam SJ, Kim YH, Kim JH, Kim HS (2021) Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: development and validation. Neuro Oncol 23:324–333. https://doi.org/10.1093/neuonc/noaa190
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Raffa G, Picht T, Scibilia A, Rosler J, Rein J, Conti A, Ricciardo G, Cardali SM, Vajkoczy P, Germano A (2019) Surgical treatment of meningiomas located in the rolandic area: the role of navigated transcranial magnetic stimulation for preoperative planning, surgical strategy, and prediction of arachnoidal cleavage and motor outcome. J Neurosurg. https://doi.org/10.3171/2019.3.JNS183411
Brokinkel B, Stummer W (2016) Brain Invasion in meningiomas: the rising importance of a uniform neuropathologic assessment after the release of the 2016 world health organization classification of central nervous system tumors. World Neurosurg 95:614–615. https://doi.org/10.1016/j.wneu.2016.08.047
Pizem J, Velnar T, Prestor B, Mlakar J, Popovic M (2014) Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33:354–363. https://doi.org/10.5414/NP300750
Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119–125. https://doi.org/10.1038/s41586-021-03850-3
Brunasso L, Bonosi L, Costanzo R, Buscemi F, Giammalva GR, Ferini G, Valenti V, Viola A, Umana GE, Gerardi RM, Sturiale CL, Albanese A, Iacopino DG, Maugeri R (2022) Updated systematic review on the role of brain invasion in intracranial meningiomas: what, when. Why? Cancers. https://doi.org/10.3390/cancers14174163
Qin C, Huang M, Pan Y, Li Y, Long W, Liu Q (2021) Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options. Brain Tumor Pathol 38:156–172. https://doi.org/10.1007/s10014-021-00399-x
Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422–433. https://doi.org/10.1038/nrc1094
Kuhn K (1995) Basement membrane (type IV) collagen. Matrix Biol 14:439–445. https://doi.org/10.1016/0945-053x(95)90001-2
Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275:1209–1215. https://doi.org/10.1074/jbc.275.2.1209
Panka DJ, Mier JW (2003) Canstatin inhibits akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem 278:37632–37636. https://doi.org/10.1074/jbc.M307339200
Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M (2005) Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 65:4353–4361. https://doi.org/10.1158/0008-5472.CAN-04-3536
Limaverde-Sousa G, Sternberg C, Ferreira CG (2014) Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents. Cancer Treat Rev 40:548–557. https://doi.org/10.1016/j.ctrv.2013.11.009
Monboisse JC, Oudart JB, Ramont L, Brassart-Pasco S, Maquart FX (2014) Matrikines from basement membrane collagens: a new anti-cancer strategy. Biochim Biophys Acta 1840:2589–2598. https://doi.org/10.1016/j.bbagen.2013.12.029
留言 (0)